1994
DOI: 10.1007/bf02353410
|View full text |Cite
|
Sign up to set email alerts
|

Predictive performance of the Bayesian analysis: Effects of blood sampling time, population parameters, and pharmacostatistical model

Abstract: The present paper reports theoretical equations for the predictive performance of the Bayesian forecasting method. The precision of parameter estimates and predicted concentrations for an individual was described by general equations with the aid of a variance-covariance matrix of parameter estimates that involved the Bayes theorem. The equations were applied to assess the predictive performance of the one-point Bayesian method in association with blood sampling time, the population parameters, and the pharmac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
11
0

Year Published

1997
1997
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 16 publications
1
11
0
Order By: Relevance
“…20) When a prediction method such as the Bayesian method is applied, it is important to know the predictability of the drug concentration and individual pharmacokinetic parameters because the predictability depends on the PPK parameters and also on the sampling time. [21][22][23] We have already evaluated the predictive performance of PPK parameters of VCM based on a two-compartment model in Japanese adult patients. 24) The pharmacokinetic variability of VCM in pediatric patients, especially neonates and premature neonates, is generally large because of the changes in body water volume and di艩erences in the extent of renal function maturation.…”
Section: Introductionmentioning
confidence: 99%
“…20) When a prediction method such as the Bayesian method is applied, it is important to know the predictability of the drug concentration and individual pharmacokinetic parameters because the predictability depends on the PPK parameters and also on the sampling time. [21][22][23] We have already evaluated the predictive performance of PPK parameters of VCM based on a two-compartment model in Japanese adult patients. 24) The pharmacokinetic variability of VCM in pediatric patients, especially neonates and premature neonates, is generally large because of the changes in body water volume and di艩erences in the extent of renal function maturation.…”
Section: Introductionmentioning
confidence: 99%
“…3, 19) ( 3) where Var(膱 ) is a variance of prediction error, f is a function of a corresponding PK model (i.e. a two-compartment infusion model), P k is the kth pharmacokinetic parameter (population mean), and m is the number of parameters.…”
Section: Evaluation Of Predicted Performancementioning
confidence: 99%
“…Var(P k ) is the variance of the kth parameter estimate approximately given by Eq. 4 19) : (4) where w 2 and s 2 are the population variances for inter-and intra-individual variations, respectively, and n is the number of observed data items used for a Bayesian prediction. The square root of Eq.…”
Section: Evaluation Of Predicted Performancementioning
confidence: 99%
See 1 more Smart Citation
“…To obviate the need for multiple blood sampling, a population approach can be used. This method is particularly suited to modeling pharmacokinetic responses in a relatively large group of subjects in which there are only limited observations, essentially very sparse data obtained during routine therapeutic drug monitoring (TDM) (11)(12)(13) NONMEM allows the estimation of population average values of pharmacokinetic parameters, such as volume of distribution (V) and clearance (CL) together with estimates of the interindividual variability in the pharmacokinetic parameters, which can be related to the modifying influence of demographic and clinical factors (covariates).…”
Section: Introductionmentioning
confidence: 99%